Osteoarthritis research advances in 2025 with David Hunter and Anne-Marie Malfait

Osteoarthritis research advances in 2025 with David Hunter and Anne-Marie Malfait

February 15, 2026 · 39 min · Season 7 · Episode 4

About this episode

The episode discusses the latest advances in osteoarthritis research in 2025 with insights from leading experts.

Hear from the co-editors-in-chief of Osteoarthritis and Cartilage journal on what they thought were the latest advances in osteoarthritis research in 2025. Anne-Marie Malfait, MD, PhD, is Professor of Medicine and the Klaus E. Kuettner, Chair of Osteoarthritis Research at Rush University. She is co-Editor-in-Chief of Osteoarthritis and Cartilage journal alongside David Hunter. RESOURCES David's papers Comparative efficacy and safety of exercise modalities in knee osteoarthritis: systematic review and network meta-analysis Clinical and cost-effectiveness of a cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial The Cost-Effectiveness of Semaglutide and Tirzepatide for Patients With Knee Osteoarthritis and Obesity Anne-Marie's paper FM-dye inhibition of Piezo2 relieves mechanically evoked pain in mouse models of acute inflammatory and osteoarthritic knee pain Association of Synovial Innate Immune Exhaustion With Worse Pain in Knee Osteoarthritis Lipidomics unravels lipid changes in osteoarthritis articular cartilage CONNECT WITH US Join one of our trials…

People in this episode

Host: David Hunter

Guest: Anne-Marie Malfait

Topics covered

Keywords

Mentioned in this episode

Organizations: Osteoarthritis and Cartilage, Rush University

More episodes of Joint Action

Explore listener stats, chart rankings, contacts and more on the Joint Action podcast page.